no scripts enabled
Search for medical products or brands
Finecare cTnI Rapid Quantitative Test  - Pack of 25 Tests (W203)

View Product Details


Finecare cTnI Rapid Quantitative Test - Pack of 25 Tests (W203)



2% Off

Exclusive of 12% GST

KYC is needed to buy this product.

See why?
Pack Size

Pack of 25 Tests

Variant unavailable, Please select another variant

Check delivery date at your location

View EMI T&C here

Purchase with Credit

Get Interest-free credit with easy and quick approval & hassle free payments

credit icon

MB Benefits

Know More


7 Day Replacement


Hassle Free

Product Details

What is in the box

25 x Tests

Description: Introducing the Finecare cTnI Rapid Quantitative Test, an advanced diagnostic tool designed for the quantitative measurement of cardiac Troponin I (cTnI). This test offers healthcare professionals a rapid and precise assessment of cardiac biomarker levels, aiding in the diagnosis and management of acute myocardial infarction (AMI) and other cardiac conditions.

Key Features:

  1. Quantitative Analysis: The Finecare cTnI Rapid Quantitative Test provides quantitative measurements of cardiac Troponin I levels, allowing for precise assessment of myocardial damage.
  2. Rapid Results: With results available within minutes, this test enables prompt clinical decision-making and timely patient management.
  3. High Sensitivity and Specificity: Engineered with high sensitivity and specificity, the test ensures accurate and reliable measurement of cTnI levels, supporting precise diagnosis and treatment.
  4. User-Friendly Design: Designed for ease of use, the test offers clear and intuitive instructions, making it suitable for healthcare professionals with varying levels of expertise.
  5. Convenient Pack Size: Each pack contains 25 tests (W203), providing healthcare facilities with a convenient and cost-effective solution for cTnI assessment.


  1. Early Diagnosis of AMI: The Finecare cTnI Rapid Quantitative Test aids in the early diagnosis of acute myocardial infarction (AMI) by providing a rapid and accurate assessment of cardiac Troponin I levels.
  2. Timely Intervention: Rapid quantitative measurement enables timely intervention and initiation of appropriate treatment strategies, leading to improved patient outcomes and reduced morbidity and mortality.
  3. Risk Stratification: Precise measurement of cTnI levels allows for effective risk stratification and prognosis assessment in patients with suspected cardiac conditions, facilitating personalized patient management.
  4. Enhanced Workflow: The rapid test format streamlines diagnostic procedures, reducing waiting times for results and optimizing resource utilization in emergency departments and cardiac care units.
  5. Cost-Effectiveness: Offering accurate results at a reasonable cost, the Finecare cTnI Rapid Quantitative Test ensures cost-effective assessment of cardiac biomarkers without compromising quality.

Sold by Raj Biosis Private Limited & fulfilled byMedikabazaar